Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Pre-Treatment	STARTED	Arm A: Nivolumab + Ipilimumab	325
Pre-Treatment	STARTED	Arm B: Nivolumab + Chemotherapy	321
Pre-Treatment	STARTED	Arm C: Chemotherapy	324
Pre-Treatment	COMPLETED	Arm A: Nivolumab + Ipilimumab	322
Pre-Treatment	COMPLETED	Arm B: Nivolumab + Chemotherapy	310
Pre-Treatment	COMPLETED	Arm C: Chemotherapy	304
Pre-Treatment	NOT COMPLETED	Arm A: Nivolumab + Ipilimumab	3
Pre-Treatment	NOT COMPLETED	Arm B: Nivolumab + Chemotherapy	11
Pre-Treatment	NOT COMPLETED	Arm C: Chemotherapy	20
Treatment	STARTED	Arm A: Nivolumab + Ipilimumab	322
Treatment	STARTED	Arm B: Nivolumab + Chemotherapy	310
Treatment	STARTED	Arm C: Chemotherapy	304
Treatment	COMPLETED	Arm A: Nivolumab + Ipilimumab	0
Treatment	COMPLETED	Arm B: Nivolumab + Chemotherapy	0
Treatment	COMPLETED	Arm C: Chemotherapy	0
Treatment	NOT COMPLETED	Arm A: Nivolumab + Ipilimumab	322
Treatment	NOT COMPLETED	Arm B: Nivolumab + Chemotherapy	310
Treatment	NOT COMPLETED	Arm C: Chemotherapy	304

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03143153/flow